1971
DOI: 10.3109/00365527109180669
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Inflammatory Drugs and Gastric Mucus

Abstract: 1971. Anti-Inflammatory Drugs and Gastric Mucus. Scartd. J . Gnstroent. 6, 49-54.The gastric mucus in the rat was studied by a histochemical technique after administration of calcium acetylsalicylate, oxiphenbutazone, and indomethacin. All these substances were found to reduce the mucus layer in the stomach. Salicylate appeared to cause the greatest reduction. and the results indicate that the effect on the gastric mucosa is partly locally and partly generally induced.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
3
0
1

Year Published

1974
1974
2012
2012

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(5 citation statements)
references
References 11 publications
0
3
0
1
Order By: Relevance
“…Gastrointestinal bleeding has been described as a side-effect of treatment with oxyphenbutazone. Administration in suppositories does not probably make any difference, because the bleeding is due to a systemic reaction and not to a local effect on the mucosa (Johansson et al 1971). In the present investigation blood in faeces was equally common before as during and after medication and was not such as to require withdrawal of the compound.…”
Section: Discussionmentioning
confidence: 38%
See 2 more Smart Citations
“…Gastrointestinal bleeding has been described as a side-effect of treatment with oxyphenbutazone. Administration in suppositories does not probably make any difference, because the bleeding is due to a systemic reaction and not to a local effect on the mucosa (Johansson et al 1971). In the present investigation blood in faeces was equally common before as during and after medication and was not such as to require withdrawal of the compound.…”
Section: Discussionmentioning
confidence: 38%
“…Schmid et al (1965) found oxyphcnbutazone in an oral dose of 800 mg a day in man to increase the secretion of the gastric juice, to produce a small decrease in pH, and to inhibit gastric peristalsis, but to have no effect on the pepsin activity. Johansson et al (1971) showed oxyphenbutazone per os to reduce the mucin content of the gastric mucosa in rats. They also deposited the drug directly in the duodenum via a tube and found it to have a similar effect on the gastric mucosa and therefore concluded that the effect was generalised.…”
Section: Adverse Effects Of Oxyphenbutazonementioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, especially due to the increasingly severe climatic conditions in city centres, a further kind of sulphate source in masonry cannot be neglected. This originates from heterogeneous oxidation [25,26] in liquid phase of sulphur dioxide contained in emissions from combustion of both light and fuel oils.…”
Section: Introductionmentioning
confidence: 99%
“…Τα οξέα έλκη τα ανα πτυσσόμενα εις τον στόμαχον και το 12/λον μετά χορήγησιν διαφόρων φαρμάκων και κυρίως άκετυλοσαλικυλικοΰ οξέος ή κατόπιν σοβαρών εγκαυμάτων, απεδείχθη οτι δεν οφείλονται εις αϋξησιν τής γαστρικής όξύτητος, ήτις παραμένει φυσιολογική ('Αθανασιάδης και συν. 1972 2 , Brodie και Hooke 1971 10 , Krantz και Carr 1965 44 , Russell και Goldberg 1970 62 , Pfeiffer και Lewandowski 1971 53 ) ή είναι ολίγον ηύξημένη (Καλλιτεράκης και Νικολαΐδης 1971) 38 , αλλά ε'ις έλάττωσιν τής ποσότητος και άλλοίωσιν τής ποιότητος τής έκκρινομένης βλέννης (Wise 1972 77 , Johanson και Lindquist 1971 35 , Reed και συν. 1968 54 , Menguy και Masters 1965 48 ), ήτις οϋτω δέν είναι πλέον ικανή να εξάσκηση τον προστατευτικόν αυτής ρόλον, μηχανικόν ή χημικόν, επί τής διαβρωτικής δράσεως του HCl επί του βλεννογόνου τοΰ στομάχου ή του 12/λου.…”
Section: εφαρμογαιunclassified